Hepatitis Co-Infection Clinic
Hepatitis C virus (HCV) affects 30% of patients at the HIV Clinic at San Francisco General Hospital. Although it is a leading cause of illness and death in HIV infection, HCV can be cured with proper treatment. New medications offer the promise of improved cure rates with shorter duration of treatment and fewer side effects.
To increase access to HCV care and cure, the UCSF HIV/AIDS Division at San Francisco General has developed a primary care based model for HCV care and treatment that includes a treatment protocol and additional resources available online at sfaetc.ucsf.edu.
All HIV patients in our clinic are tested for HCV and those who test positive are provided with specific care and treatment through the HIV primary care clinic. Key components of this primary care based model include:
- HCV Support and Education Group: The weekly support group is run by an experienced HCV nurse and a peer educator who has been through HCV treatment. The group is a critical component of patient education about HCV, providing the groundwork for treatment readiness as well as support to patients who are undergoing HCV treatment
- Interdisciplinary Team: Our Hepatitis Coinfection Clinic meets twice monthly. Components of our team based approach to HCV care include
- HCV Treatment Nurse: Coordinate clinical and programmatic services, provide education to patients, facilitate support group and monitor patients on HCV treatment
- Social worker: Evaluate mental health and factors affecting treatment readiness, including housing, benefits, substance use and social support
- Psychiatrist/Mental Health provider: Assess mental health stability and HCV treatment readiness and manage psychiatric complications of treatment
- Pharmacist: Evaluate drug-drug interactions and work with insurance plans to provide access to HCV medications
- Peer Educator: Provide education and support from the perspective of someone who has been through hepatitis C treatment
- Physician: Perform comprehensive pre-treatment evaluation and management of side events during therapy
- Integration of clinical research. Given the rapidly changing field of HCV treatment and the active HCV clinical research program within the HIV Division, patients are offered the opportunity to participate in cutting-edge clinical trials
For more information contact Val Robb, RN at firstname.lastname@example.org.